Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Nov 19 2025
Mar 18 2026
Dec 4 2025
Feb 28 2026
Nov 28 2025